Iodine-131–labelled small-molecule radiopharmaceutical that selectively binds and destroys partially necrosed tumor tissue via targeted radiation. Indication-agnostic adjuvant for a wide range of solid tumors, intended for use alongside therapies that create tumor necrosis; preclinical data and a clinical formulation exist with early clinical studies planned.